Alabama (WHNT) — 42 states, including Alabama, will receive part of a nationwide settlement with the life-saving drug maker for allegedly illegally exploiting its market.
sub boxon (buprenorphine and naloxone) are used to treat opioid addiction in adults
“Indiviol has illegally exploited the market to maintain its monopoly on Saboxone and restricted critical access to this life-saving drug,” said AG Marshall. “I will continue to hold pharmaceutical companies accountable if they violate the law and harm the public.
The Northchesterfield, Virginia-based drug company has denied wrongdoing in settling a lawsuit filed by multiple states in 2016, saying the company is “trying to disrupt the market for pills while at the same time doing illegal business.” We used our means to switch the Suboxone market from tablets to films and try to keep the market going.” drug monopoly,” the announcement said.
according to ReutersThe Suboxone was approved for sale in 2002, and Indivior had exclusive rights to market it in tablet form until 2009.
The trial was scheduled to begin in September.
The agreement remains subject to approval by the Eastern District Court of Pennsylvania and is also subject to terms of the negotiations, including further disclosure to the states to ensure the company does not use anti-competitive tactics. .
Other states participating in the litigation led by Wisconsin are Alaska, Arkansas, California, Colorado, the District of Columbia, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Nebraska, New Hampshire, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Utah, Vermont, Virginia, Washington, Western Virginia.
https://www.wkrg.com/alabama-news/1-3-million-allotted-for-alabama-amid-settlement-for-opioid-treatment-drug/ Alabama Allocated $1.3 Million During Opioid Drug Settlement